Search Details

Word: cancers (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...clinical uncertainties need to be addressed as well. Tamoxifen reduces the risk of noninvasive breast cancers (ductal carcinoma in situ and lobular carcinoma in situ), while raloxifene does not. "Expert opinion is going to be very important in interpreting this," says Dr. Len Lichtenfeld of the American Cancer Society. "We're certainly looking forward to all the information being examined and discussed...

Author: /time Magazine | Title: Health: A Better Option? | 4/24/2006 | See Source »

...pros and cons of raloxifene for their bone health may decide to add the STAR results to the plus side of the equation. Meanwhile, other studies are under way to determine if a different group of drugs, called the aromatase inhibitors, might be more effective at preventing breast cancer than either tamoxifen or raloxifene. Breast-cancer research is such a fast-moving field that it often seems as though something better is just over the horizon...

Author: /time Magazine | Title: Health: A Better Option? | 4/24/2006 | See Source »

...study included 19,747 postmenopausal women who were at high risk of developing breast cancer...

Author: /time Magazine | Title: Health: A Better Option? | 4/24/2006 | See Source »

More than 1,100 participants raised $150,200 for cancer survivors and cancer research Friday night, in the third annual Relay for Life at Harvard’s Gordon Track. The twelve-hour event, attended by students, faculty, and relatives from eight area colleges is part of the American Cancer Society (ACS)’s largest and most successful national fundraising campaign to date. The event raises money for cancer research, much of which goes to Harvard professors in the field. The relay is also meant to raise awareness. “Fundraising is a big part of Relay...

Author: By Nadia A Gaber, CONTRIBUTING WRITER | Title: Relay Race Helps Profs Fight Cancer | 4/24/2006 | See Source »

...have important implications for branches other than stem cell medicine as well. “I think that understanding how these sorts of bivalent structures contribute to the unique potential of these kind of cells has important implications not only for stem cell biology and regenerative medicine, but for cancer and other diseases where chromatin misregulation or deregulation is involved,” Bernstein said...

Author: By Shaunak A. Vankudre, CONTRIBUTING WRITER | Title: Researchers Make Stem Cell Find | 4/24/2006 | See Source »

Previous | 417 | 418 | 419 | 420 | 421 | 422 | 423 | 424 | 425 | 426 | 427 | 428 | 429 | 430 | 431 | 432 | 433 | 434 | 435 | 436 | 437 | Next